Wild-type p53 gene increases MDR1 gene expression but decreases drug resistance in an MDR cell line KBV200

被引:23
|
作者
Li, ZH
Zhu, YJ
Lit, XT
机构
[1] CHINESE ACAD MED SCI, INST CANC, DEPT PHARMACOL, BEIJING 100021, PEOPLES R CHINA
[2] BEIJING UNION MED COLL, BEIJING 100021, PEOPLES R CHINA
[3] CHINESE ACAD MED SCI, INST CANC, DEPT BIOCHEM, BEIJING 100021, PEOPLES R CHINA
基金
中国国家自然科学基金;
关键词
p53; gene; MDR1; drug resistance; anticancer drug; apoptosis;
D O I
10.1016/S0304-3835(97)00267-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Inactivation of p53 gene and overexpression of MDR1 gene are both associated with drug resistance, Previous studies have suggested that p53 gene can modulate the expression activity of MDR1 gene promoter in a promoter-CAT system. In the present study, wild-type p53 gene cDNA was introduced into a multidrug-resistant cell line, KBV200, in which endogenous p53 gene is aberrant. In wt-p53 transfected cells, the expression of MDR1 gene was significantly increased, accumulation of adriamycin (ADM) was decreased, and the sensitivity to vincristine (VCR), ADM and 5-fluorouracil (5-FU) was increased compared with the parent KBV200 cells, After treatment with ADM and VCR, the p53-transfectants were more susceptible to apoptosis. The results suggest that the increase in drug sensitivity of the cells may be, at least in part, due to p53-dependent apoptosis induced by anticancer agents. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:177 / 184
页数:8
相关论文
共 50 条
  • [31] MDR-1 gene and p53 as prognostic markers in choriocarcinomas
    Lin, O
    Abadi, MA
    Jones, WB
    Saigo, PE
    MODERN PATHOLOGY, 1998, 11 (01) : 108A - 108A
  • [32] The MDR1 gene and intracellular glutathione in drug resistance in human leukaemia: Implications for overcoming MDR with PSC 833
    Jiang, XR
    Kelsey, SM
    Devadasan, C
    Gutteridge, CN
    Newland, AC
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 3 - 3
  • [33] Wild-type p53 marginally induces endogenous MDR-1 mRNA without causing a measurable drug resistance in human cancer cells
    Nicoletti, MI
    Myers, TG
    Fojo, T
    Blagosklonny, MV
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 18 (02) : 375 - 381
  • [34] Multi-drug resistance (MDR1) gene identification and sequence in horses
    Linardi, Renata L.
    Natalini, Claudio C.
    Kousoulas, Konstantin G.
    Huang, Li Ju Ti
    Stokes, Ashley Michelle
    Moore, Rustin M.
    FASEB JOURNAL, 2009, 23
  • [35] The MDR1 gene and intracellular glutathione in drug resistance in human leukaemia: Implications for overcoming MDR with PSC 833
    Jiang, XR
    Kelsey, SM
    Devadasan, C
    Gutteridge, CN
    Newland, AC
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1323 - 1323
  • [36] Comparison of the effect of mutant and wild-type p53 on global gene expression
    O'Farrell, TJ
    Ghosh, P
    Dobashi, N
    Sasaki, CY
    Longo, DL
    CANCER RESEARCH, 2004, 64 (22) : 8199 - 8207
  • [37] Wild-type p53-mediated induction of rat mdr1b expression by the anticancer drug daunorubicin
    Zhou, G
    Kuo, MT
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (25) : 15387 - 15394
  • [38] P-Glycoprotein/MDR1 Regulates Pokemon Gene Transcription Through p53 Expression in Human Breast Cancer Cells
    He, Shengnan
    Liu, Feng
    Xie, Zhenhua
    Zu, Xuyu
    Xu, Wei
    Jiang, Yuyang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2010, 11 (09): : 3039 - 3051
  • [39] RELATIONSHIP BETWEEN P53 GENE-MUTATIONS AND MULTIDRUG-RESISTANCE (MDR(1)) GENE-EXPRESSION IN MYELODYSPLASTIC SYNDROMES
    PREUDHOMME, C
    LEPELLEY, P
    VACHEE, A
    SOENEN, V
    QUESNEL, B
    COSSON, A
    FENAUX, P
    LEUKEMIA, 1993, 7 (11) : 1888 - 1890
  • [40] EXPRESSION OF THE MULTIDRUG-RESISTANCE GENE (MDR1) IN NONSMALL CELL LUNG-CANCER
    ABE, Y
    NAKAMURA, M
    OTA, E
    OZEKI, Y
    TAMAI, S
    INOUE, H
    UEYAMA, Y
    OGATA, T
    TAMAOKI, N
    JAPANESE JOURNAL OF CANCER RESEARCH, 1994, 85 (05): : 536 - 541